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ABSTRACT: 
Insulin secreting β-cells are heterogeneous in their regulation of hormone release. While long 
known, recent technological advances and new markers have allowed the identification of 
novel subpopulations, improving our understanding of the molecular basis for heterogeneity. 
This includes specific sub-populations with distinct functional characteristics, developmental 
programs, abilities to proliferate in response to metabolic or developmental cues, and 
resistance to immune-mediated damage. Importantly, these sub-populations change in 
disease or in aging, including in human disease. While discovering new β-cell sub-
populations has substantially advanced our understanding of islet biology, a point of caution 
is that these characteristics have often necessarily been identified in single β-cells 
dissociated from the islet. β-cells in the islet show extensive communication with each other 
via gap junctions, and with other cell types via diffusible chemical messengers. As such, how 
these different sub-populations contribute to in-situ islet function, including during plasticity, is 
not well understood. We will discuss recent findings revealing functional β-cell sub-
populations in the intact islet, the underlying basis for these identified sub-populations, and 
how these sub-populations may influence in-situ islet function. Furthermore, we will discuss 
the outlook for emerging technologies to gain further insight into the role of sub-populations in 
in-situ islet function.  
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Introduction to β-cell heterogeneity: 
A β-cell is a terminally differentiated cell that produces and secretes insulin in a glucose-
regulated manner. Importantly, β-cells have the ability to adapt to changes in metabolic 
demand through increased insulin secretion and/or number. In most vertebrate species β-
cells form clusters with other hormone secreting cells (glucagon-secreting α-cells, 
somatostatin-secreting δ-cells) within islets of Langerhans. Very early studies of the β-cell 
assumed them to be homogenous based on a lack of morphological differences. However, 
detailed studies subsequently determined that there exists a broad heterogeneity in the 
function of β-cells. These early studies of β-cell heterogeneity are summarized by the 
landmark review of Pipeleers (1), which describes with remarkable foresight the presence, 
characteristics and role of functional β-cell sub-populations. This includes how dissociated β-
cells show functional heterogeneity, with populations of cells displaying higher levels of 
glucose metabolism, redox state, insulin synthesis, membrane potential, and insulin 
secretion; that morphological markers (nuclear size, insulin granularity) can differentiate β-cell 
sub-populations with differing glucose sensitivity and insulin secretion levels; that β-cells 
show heterogeneous expression of key proteins such as glucokinase (GCK), connexins, or 
insulin, including spatial variations across the islet; that β-cells with low glucose-stimulated 
insulin secretion preferentially increase in number under development or metabolic stress; 
and that β-cells vary in their sensitivity to cytotoxic agents. Despite this in-depth knowledge, 
there have been several gaps in our understanding that have persisted until recently: 
i) What is the molecular basis for β-cell functional diversity? 
ii) Which markers can be used to identify and characterize β-cell sub-populations?  
iii) Does functional heterogeneity in the intact islet or pancreas mirror that observed among 
dissociated β-cells? 
iv) What is the role of β-cell heterogeneity in islet function and glucose homeostasis, and 
can changes in heterogeneity contribute to diabetes? 
v) Are β-cells fixed in specific functional states, or can they transition between states over 
time? 
We will describe recent technological advances and studies that have answered some of 
these key questions, with a focus on understanding the consequence of heterogeneity in β-
cell function within the islet setting.  
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Recent advances characterizing β-cell heterogeneity:  
Early and more recent studies demonstrated heterogeneity in insulin secretion in dissociated 
mouse or human β-cells using the hemolytic plaque assay (2). Patch clamp measurements 
also revealed heterogeneity in dissociated β-cell electrical properties (3). Autofluorescence 
measurements revealed heterogeneity in redox state, and incorporation of radioactive tracers 
revealed heterogeneity in glucose metabolism and insulin biosynthesis (4). The development 
of fluorescent biosensors and confocal or 2-photon microscopy provided tools to further 
characterize β-cell functional differences. This includes precise quantification of heterogeneity 
in dissociated β-cell glucose metabolism and redox state (5); glucose sensitivity to Ca2+ 
elevations and Ca2+ oscillation patterns (6); and cAMP oscillation patterns (7). Recently, the 
application of new biomarkers or high-throughput single-cell analyses has further revealed 
molecular details underlying β-cell heterogeneity.  
 
Markers of β-cell sub-populations: Early studies suggested insulin granularity was a 
morphological marker that could separate a population of β-cells with a low glucose threshold 
(4). More recently, several markers have been employed that reveal β-cell sub-populations 
with differing function. Polysialylated (PSA)-NCAM separated two populations of mouse β-
cells, with one population (βhigh) showing higher Ca2+ and ATP elevation, insulin secretion, as 
well as Gck and Glut2 expression (8). Insulin promoter activity (MIP-GFP fluorescence) 
separated three populations of β-cells, with the MIP-GFPlow population (~10% incidence in 
adult) possessing low insulin expression and low granularity (9). Aguayo-Mazzucatio and 
coworkers subsequently showed that the MIP-GFPlow and MIP-GFPhigh populations 
decreased and increased in incidence, respectively, during aging (10). Further, the MIP-
GFPlow population was not marked by increases in the aging markers IGF1R or p16Ink4a, the 
lack thereof indicative of newly formed cells. The authors also showed that a population of 
highly secreting cells is lost during aging. However, the low incidence of this population (~5%) 
is suggestive of a subset of MIP-GFPhigh cells. Recently, Lickert and coworkers utilized a Fltp-
Venus reporter mouse to separate two populations of β-cells. Fltp-Venus positive (Fltp+) cells 
showed improved insulin secretion but reduced proliferative ability (11), together with more 
extensive mitochondrial morphology, more oxidative metabolism, and increased insulin 
granularity. The genetic profile of Fltp+ cells was also consistent with improved function (i.e. 
increased expression of genes for GCK, GLUT2, GLP1R, GIPR, Cx36), as well as increased 
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maturity. Notably, during development or upon metabolic stress the Fltp- population showed 
greater proliferation and number. These studies together indicate a dynamic β-cell sub-
population defined by improved glucose-stimulated insulin secretion as a result of elevated 
glucose metabolism and insulin granule content. 
Huising and coworkers employed a Ucn3 reporter mouse revealing a population of 
insulin+ Ucn3- cells undergoing α-cell to β-cell transition at the intact islet periphery (12). 
These immature cells showed decreased expression of genes regulating glucose metabolism 
(Gck, TCA cycle, oxidative phosphorylation), membrane potential (KATP, CaV subunits), as 
well as Glp1r and Ins. They also lacked both glucose influx and glucose-regulated membrane 
potential and Ca2+ influx. While reminiscent of sub-populations with reduced function, this 
population is much lower in incidence (~2%), shows negligible glucose sensitivity, and is not 
differentiated by markers such as Fltp. As such, this represents a novel cell sub-population. 
Herold and coworkers also identified a population of β-cells in non-obese diabetic (NOD) 
mice characterized by reduced granularity that increased in number during autoimmune 
attack of the islet (13). This population also displayed reduced levels of insulin, GLUT2 and 
maturity markers, consistent with earlier studies (1). Thus, rarer sub-populations of β-cells do 
exist, although how they overlap is not known. 
In human β-cells, Grompe and coworkers identified two surface markers (CD9, 
ST8SIA1) that separated four populations of β-cells with distinct gene expression profiles 
(14). ST8SIA1+ cells (~15% in healthy donors) showed lower insulin secretion, lower 
expression of GLUT2, but increased expression of genes encoding KATP channel subunits 
and other K+ channels. The incidence of ST8SIA1+ cells is also increased in type 2 diabetic 
donors.  
While these markers all separate β-cell populations with distinct functional states, 
further less well characterized sub-populations have been identified using other markers and 
the reader is referred to (15). However, it is important to remember that markers are not 
generally associated with driving the functional state of the β-cell sub-population. For 
example, a Fltp deletion has minor impact on β-cell function (11). Thus, PSA-NCAM or 
CD9/ST8SIA1 may simply separate differing populations in an arbitrary manner. Furthermore, 
it is not always clear whether fluorescent reporter constructs reflect the protein level: for 
example, MIP-GFPmedium and MIP-GFPhigh β-cells show identical insulin transcription and 
protein levels (9), and the change in Fltp gene transcription only varies ~2-fold between Fltp+ 
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and Fltp- cells defined by the Fltp-Venus reporter (11). Thus, great care should be taken 
when linking the marker involved to the characteristics of the sub-population in question. 
 
High-throughput single-cell analysis: In an elegant study, Kaestner and coworkers employed 
mass-cytometry to detect large numbers of protein markers in human β-cells, indicating three 
consistent β-cell states (C1, C2, C3) (16). One state (C1, 10-70% in adult) showed 
substantially lower proliferation than the other two states (C2, C3), where the proportion of C1 
increased with age and decreased in obesity. While limited probes for proteins involved in β-
cell function were employed, the C1 population showed higher PDX1 and insulin expression 
indicative of a mature functional population. The C1 population also showed lower ST8SIA1 
and CD9 levels compared to proliferating C2, C3 populations; where previously ST8SIA1- 
and CD9- β-cells showed improved insulin secretion and maturity markers, and decreased in 
T2D (14).  
Single-cell sequencing has been used by several groups to examine the transcriptional 
profile in islet endocrine cells (16-18) (for comprehensive reviews on this topic, see (15;19)). 
This has also resolved sub-populations of β-cells in humans (17), identifying five β-cell states. 
Interestingly, all showed similar insulin expression, but differed in gene transcription that 
included free-fatty acid receptor 4 and RBP4 (an adipokine receptor). However, it remains 
unclear whether these states overlap with those revealed by mass-cytometry or markers 
described to date. Further, no clear heterogeneity was detectable using similar analyses in 
mouse β-cells (20), questioning whether this may reflect true species differences, a reduction 
in variability due to use of syngeneic donors maintained in controlled housing conditions, or 
an effect of isolation protocol. Moreover, single cell analysis characterizes heterogeneity in 
dissociated β-cells, and islet dissociation may bias the population of cells that are analyzed, 
for example due to reduced β-cell viability. Integration of multiple factors (e.g. environmental 
stimuli, developmental cues, cell cycle and tissue architecture) that affect cell identity will also 
be important in future studies to robustly define sub-populations (21).  
 
Interpreting sub-populations from marker and single cell analyses: Fig.1 summarizes the 
functional β-cell sub-populations identified by recent marker and single-cell sequencing 
studies and their relative overlap in characteristics. Bearing in mind potential limitations in 
marker studies or high throughput single cell studies, these studies consistently show a 
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mature population of β-cells (incidence 50-80%) that is functionally competent, probably due 
to higher rates of oxidative metabolism and ATP production, high levels of insulin expression, 
granule content and secretion, and potentially improved electrical properties. This population 
reduces in incidence or shows dysfunction under aging and diabetes, possibly due to 
increased susceptibility to ER stress (22). Conversely, the opposing less-mature population 
(incidence 15-50%) shows reduced insulin secretion secondary to reductions in glucose 
metabolism and insulin expression, but has improved proliferative capacity.  
While some studies indicate that >2 populations exist (e.g. MIP-GFPlow/medium/high, 
CD9+/-/ST8SIA1+/-), it is unclear whether the ‘functionally competent’ and ‘less functional’ 
populations can be further subdivided. Likely, there exist small distinct sub-populations, such 
as the Ucn3- insulin+ neogenic niche, with some similarities to the ‘less functional’ population. 
Future work will require care when determining whether identified sub-populations truly are 
distinct, or whether they are an artifact of the analysis employed. For example, does 
increasing the number of markers generate more or less apparent/overlapping β-cell 
populations, or can populations be reproduced in a second dataset (e.g. using training and 
test sets)? Can absence of a subpopulation be excluded given the relatively poor resolution 
of ‘omics approaches such RNASeq, where even at 6,000M reads a proportion of genes 
remains unquantified? 
Importantly, most studies to date described above have characterized sub-populations 
using single-cell preparations that lack the influence of the interactions between β-cells and 
other cell types within the islet. While re-aggregation methods can recover some of these 
influences, it is still unclear how different sub-populations may interact within the islet to 
influence islet function. Therefore, proper consideration of how a heterogeneous population 
of β-cells functions within the islet is needed.  
 
How heterogeneous cells interact in the islet: 
Interactions between cells within the islet are critical: dissociation of the islet into single β-
cells reduces the dynamic range of glucose-stimulated insulin secretion by ~10-fold (23). 
Even when β-cells remain coupled to one or two other β- or α-cells, insulin secretion 
significantly improves (24). While many mechanisms of cell-cell communication have been 
identified, less is known about how they coordinate heterogeneous cell populations.  
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Gap junction electrical coupling between heterogeneous cells: Gap junction (GJ) channels 
electrically couple β-cells within mouse and human islets (25), serving two main functions. 
Firstly, GJ channels coordinate oscillatory dynamics in electrical activity and Ca2+ under 
elevated glucose or GLP1, allowing pulsatile insulin secretion (26;27). Secondly, GJ channels 
lower spontaneous elevations in Ca2+ under low glucose levels (28). GJ coupling is also 
heterogeneous within the islet (29) leading to some β-cells being highly coupled, yet others 
showing negligible coupling.  
Several studies have examined how electrically heterogeneous cells interact via GJ 
channels using KATP channel mutant mice (Fig.2). The Kir6.2[ΔN30,K185Q] mouse model CreER-
dependently expresses overactive KATP channels in a population of β-cells, rendering them 
inexcitable (30). By varying recombination efficiency, as few as ~15% inexcitable β-cells was 
found to be sufficient to suppress Ca2+ responses to glucose across the islet (30). Thus, small 
numbers of inexcitable cells can cause marked dysfunction by suppressing islet electrical 
activity and insulin secretion. Similar conclusions were made using the Kir6.2[AAA] mouse 
model that expresses inactive KATP channels in ~70% of β-cells, rendering them hyper-
excitable (31). Despite the majority of β-cells lacking glucose-regulated KATP closure, islets 
from these mice showed near-normal responses, since the remaining ~30% of normal β-cells 
were sufficient to regulate islet Ca2+ (31). In each case, a deficiency in GJ channels led to 
KATP mutant cells and normal cells behaving distinctly (30;31). Thus, GJ coupling is a major 
mechanism by which electrically heterogeneous cells interact. Early studies imposing 
metabolic heterogeneity through a knockout of GCK in a population of β-cells did not find 
evidence of significant ‘metabolic coupling’ between β-cells (32). 
This series of experiments indicate a ‘bistability’ in islet function, where a threshold 
number of poorly-responsive β-cells is sufficient to totally suppress islet function. Notably, 
when islets lacking GJ channels are treated with low-levels of the KATP activator diazoxide or 
the GCK- inhibitor mannoheptulose, a sub-population of cells are silenced, presumably 
corresponding to the ‘less functional’ population (30). Only diazoxide/mannoheptulose 
concentrations capable of silencing >40% of these cells will fully suppress Ca2+ elevations in 
normal islets. Again this indicates that a threshold number of poorly-responsive cells can 
inhibit the whole islet. Thus, if there exists a threshold number of functionally competent β-
cells (~60-85%), then the islet will show coordinated elevations in Ca2+ and insulin secretion. 
Below this threshold number, the islet will lack Ca2+ elevation and insulin secretion (Fig.2). 
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The precise threshold depends on the characteristics of the excitable and inexcitable 
populations: small numbers of inexcitable cells will increase the number of functionally 
competent cells required for islet activity, whereas small numbers of highly excitable cells will 
do the opposite. However, if GJ coupling is lowered then inexcitable cells will exert a reduced 
suppression, also decreasing the threshold required.  
  
Paracrine and juxtacrine communication: Paracrine communication between β-cells and other 
endocrine cells is also important for regulating insulin secretion. Complex cross-talk between  
α- and β-cells- stemming from neurotransmitters, ions and hormones- shapes glucagon and 
insulin secretion depending on glucose concentration (reviewed in (33)). δ-cell somatostatin 
secretion also inhibits insulin secretion. Notably, Ucn3 co-secreted with insulin promotes 
somatostatin secretion, leading to negative feedback against overt fluctuations in insulin 
secretion (34). Therefore, dynamic inter-communication exists between the main endocrine 
cells types within the islet. Several neurotransmitters (e.g. acetylcholine, glutamate, GABA) 
are also released within the islet by nerve terminals and endocrine cells, which can modulate 
insulin secretion and act on other endocrine cells (reviewed in (35)). 
Juxtacrine or contact-dependent communication includes EphA-ephrinA bidirectional 
signaling between β-cells (36). EphA forward signaling predominates at elevated glucose and 
promotes insulin secretion, but ephrinA reverse signaling predominates at low glucose and 
suppresses insulin secretion (36). NCAM signaling between β-cells also promotes insulin 
secretion (8). 
Little is known how these paracrine and juxtacrine mechanisms impact heterogeneous 
cells. One possibility is a homogenizing effect: for example, given heterogeneity some β-cells 
will secrete more insulin and co-secrete more Ucn3, thus stimulating more local somatostatin 
secretion. As a result, there may be a greater local suppression of insulin secretion creating 
more homogeneous release. Whether such an homogenizing effect occurs with the various 
paracrine communication feedback loops (e.g. somatostain-Ucn3, glucagon-insulin) remains 
to be determined. Similarly, juxtacrine mechanisms may impact heterogeneous cells 
differently, particularly give heterogeneity in β-cell glucose metabolism. However, these 
actions also remain to be determined.  
 
Heterogeneity in the intact islet: 
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Functional heterogeneity in the islet, in terms of glucose metabolism (NADH response, GCK 
expression) (32;37), has been long known. While electrical activity and cAMP responses are 
apparently homogeneous in the islet (26;38), this is likely due to GJ coupling. In the absence 
of GJ coupling the electrical response is heterogeneous in terms of glucose sensitivities and 
patterns of Ca2+ oscillations (26). Despite several aspects of function being homogeneous in 
the islet, β-cell sub-populations can dramatically influence overall islet function as discussed 
above.  
 
A role for existing sub-populations?: MIP-GFPhigh, PSA-NCAMhigh, Fltp+, ST8SIA1- 
‘functionally competent’ β-cell sub-populations all show similar characteristics with incidences 
of 50-80%. Given our understanding of how heterogeneous cells interact via GJ coupling it is 
tempting to speculate that the opposing ‘less functional’ β-cell sub-population (i.e. MIP-
GFPlow, PSA-NCAMlow, Fltp-, ST8SIA1+; 15-50%) could significantly suppress islet activity via 
electrical coupling. However, Fltp- cells showed a marked reduction in Gjd2 expression 
encoding Cx36, which would be expected to reduce their ability to suppress Ca2+ elevations 
across the islet, thus allowing for normal islet function. As such, the increased number of Fltp- 
cells in development or metabolic stress will likely not impair islet function. Whether MIP-
GFPlow, PSA-NCAMlow, or ST8SIA1+ cells show reduced Gjd2/Cx36 expression remains to be 
determined. Therefore, as a result of functional remodeling, the smaller ‘less functional’ 
immature β-cell population within the islet is unlikely to have a detrimental effect on overall 
islet function. However, until recently it has been unclear whether further sub-divisions within 
the ‘functionally competent’ sub-population have a disproportionate role within the islet, in 
part owing to a lack of means to discover these sub-divisions.  
 
Optogenetics: Interrogation of β-cell function within islets requires technologies with high 
spatio-temporal resolution to capture and manipulate signaling events that occur throughout 
the islet. This can be achieved using optogenetics, where ion channels or pumps derived 
from light-sensitive bacteria are recombinantly expressed in the cell membrane to optically 
modulate electrical excitability and β-cell function (39). Combined with high-speed optical 
imaging, this provides a powerful platform for understanding sub-population function. 
Pioneering studies by Reinbothe and co-workers showed the utility of channelrhodopsin-2 
(ChR2), a light-activated cation channel, to modulate islet Ca2+ fluxes using a blue light (39). 
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Later studies used Halorhodopsin (eNpHR3.0), an orange light-activated Cl- pump, as well as 
ChR2 to selectively silence or activate single β-cells, as well as clusters and larger regions 
(40;41) (Fig.3).  
 
Using optogenetics to discover and understand β-cell sub-populations: Optogenetic mapping 
has provided evidence that a small subset of ‘functionally competent’ β-cells may play a 
disproportionate role in orchestrating islet responses to glucose (Fig.3) (40). Random 
activation of single β-cells using ChR2 revealed significant elevation of [Ca2+]i in neighboring 
regions in ~50% of cases, presumably corresponding to the ‘functionally competent’ β-cell 
sub-population. However, substantial activation was achieved in rare cases (~5%), with Ca2+ 
spreading throughout large portions of the islet. Supporting an important link between 
glucose metabolism and heterogeneity indicated in prior studies, elevation of Ca2+ was most 
effective in stimulated cells that had the highest NAD(P)H responses (41). Furthermore, a 
separate sub-region of β-cells was identified, characterized by low NAD(P)H responses, that 
showed high intrinsic oscillatory frequencies and corresponded to initiating Ca2+ wave 
propagation (41). Along similar lines, targeted silencing using eNpHR3.0 highlighted a sub-
population (~1-10%) of metabolically-adapted β-cells involved in supporting islet-wide Ca2+ 
dynamics (40). These cells, termed ‘hub cells’, were typified by elevated GCK content and 
hyperpolarized mitochondria, highly consistent with other ‘functionally competent’ sub-
populations. However, they also possessed ~2-5-fold lower protein expression levels of 
Pdx1/Nkx-6.1/insulin indicating relative immaturity, although all three markers were still 
detectable (Fig.1 and Fig.3). Whether eNpHR3.0-defined ‘hub’ and ChR2-defined 
subpopulations are fixed in time or dynamic remains unknown due to the inability to record for 
more than a few hours, although longitudinal intravital imaging techniques may aid this (42). 
That these more distinct populations were missed in biomarker analysis or high throughput 
single-cell analysis likely indicates the importance of their presence in the intact islet for 
function, and further argues for the importance of studying β-cell heterogeneity in the islet 
context.  
An improvement in metabolic properties and function in hub cells is difficult to 
reconcile with a loss of β-cell identity. However, it is worth noting that glucose-stimulated 
insulin secretion in MafA deficient β-cells (i.e. less mature) is only reduced by ~50% with 
minimally-affected NAD(P)H responses (43), and islets deficient in GLUT2 display preserved 
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second phase insulin secretion (44). Moreover, recent studies have shown that immature, 
proliferative β-cells highly express genes involved in amino acid metabolism and 
mitochondrial function (45). Lastly, sub-populations of mouse β-cells exist with high Gck, but 
low Pdx1/Nkx6-1 (20), as well as low insulin expression (46). Thus, these data indicate a sub-
division within the ‘functional’ population in the islet, raising interesting questions about the 
role of β-cell identity in islet function and insulin secretion.  
 
Extrapolating single-cell to islet studies: Some caution is required when trying to extrapolate 
results between transcriptional and functional studies. As discussed above, it is well 
acknowledged that tissue architecture influences gene expression and dissociated cell mRNA 
profiles may not necessarily reflect those in-situ (47). Isolation of single cells is usually 
associated with decreases in viability. While these cells are excluded from RNA-Seq 
analyses of purified populations, some sub-populations, including hub cells (40) or those that 
express low SERCA2/low Pdx1 (48), appear more susceptible to ER stress and 
apoptosis/cell death. As such their gene/protein expression levels may not be fully captured. 
Lastly, there is a tendency to classify and label sub-populations, whereas β-cells likely 
occupy an overlapping continuum due to the dynamic nature of gene transcription (47). Thus, 
a major obstacle to our present understanding of heterogeneity is the inability to track 
transcriptional/protein dynamics in single β-cells in-situ and over long time-scales. 
 
Islet heterogeneity in-vivo: Islets are highly vascularized and pioneering intravital imaging 
studies in mice have shown that islet blood flow is directional, perfusing α-cells before β-cells 
(49). Key to understanding heterogeneity in-vivo will be experiments using islets transplanted 
into the anterior chamber of the eye (ACE) (42), where blood and neural supplies remain 
intact. Combined with optogenetics and reporter gene imaging (see below), this provides a 
powerful means to longitudinally image the plasticity of sub-populations across lifespan. 
However, the ACE is unable to recapitulate normal pancreatic physiology (e.g. endocrine-
exocrine interactions), and immune infiltration has been reported (50).  
 
Future tools for the interrogation of β-cell heterogeneity: 
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We have argued the importance for resolving and studying β-cell heterogeneity in the context 
of the intact islet. While we have discussed several new technologies that have been 
developed and applied to examine β-cell heterogeneity, additional technologies show great 
promise for studying β-cell heterogeneity in-situ.  
 
Photopharmacology: describes the synthesis of pharmacophores bearing azobenzene 
photoresponsive elements whose inactive and active states can be controlled by light through 
cis- and trans-isomerization. These approaches have been applied to anti-diabetic agents 
including sulfonylureas or incretin-mimetics (51). A major advantage of photopharmacology 
over optogenetics is the ability to control endogenous targets without the need for 
recombinant approaches thus providing high-utility for targeting human β-cells. However, 
these approaches tend to be non-binary, with some drug activity seen even with ‘inactive’ or 
unilluminated compound, which can complicate functional interrogation of beta cell signaling. 
 
MALDI imaging: Matrix-Assisted Laser Desorption Ionization (MALDI) is a label-free method 
that provides information on endogenous proteins, metabolites, lipids and hormones. This 
requires application of a matrix to allow absorption of laser energy followed by desorption and 
liberation of single protonated species, whose time-of-flight (TOF) is ranked according to 
analyte. While the spatial resolution of MALDI-TOF is low (20-200 µm), many endogenous 
markers can be studied simultaneously in-situ with high sensitivity. As such, it may be useful 
for understanding heterogeneity between individual islets or islet regions (52), although the 
technique is temporally limited due to the requirement to use fixed tissue.  
 
Multiplexed ion beam imaging: Mass-cytometry overcomes limitations in channel number with 
conventional flow cytometry by using rare-earth labelled antibodies and TOF detection. This 
enables large (>40) protein panels to be studied and has been applied to dissociated human 
β-cells resolving three distinct sub-populations (16). Technology using rare-earth metal 
labelling and TOF detection has been adapted into an imaging format- Multiplexed Ion Beam 
Imaging (MIBI)- that can achieve sub-cellular spatial resolution (53). Therefore, imaging of 
islets in-situ, including in intact pancreas preparations will be achievable. One potential 
limitation will be the availability of compatible metal-labelled antibodies against proteins 
involved in β-cell function (e.g. GCK/ion channels/GPCRs). 
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Reporter gene imaging: Gene expression dynamics (47) may add another level of 
heterogeneity to β-cell function, and potentially explain some of the differences in β-cell sub-
populations observed to date. Early studies by Szabat and co-workers used a Pdx1-
mRFP/Ins1-GFP dual reporter to show the existence of a Pdx1+/Inslow sub-population (46). A 
similar approach can be envisaged using a combination of fluorophores with long and short 
half-lives to allow measurement of protein expression dynamics (as an indirect readout for 
gene expression) in the intact islet setting, as well as examine plasticity in β-cell sub-
populations. However, the disadvantage of such approaches is the inability to visualize 
transcription/translation of endogenous genes/RNAs, or account for posttranscriptional 
regulation.  
 
RNA FISH: Fluorescent in-situ hybridization (FISH) allows nascent RNA to be labeled, 
providing a snapshot of transcription. High-throughput single-cell FISH has been applied to 
examine changes in mRNA levels for β-cell “repressed” genes during proliferation (54). 
Closer examination of the FISH data revealed marked differences between individual β-cells 
(10-100-fold), suggesting heterogeneity at the transcript level (54). By using higher resolution 
single-molecule detection (fliFISH) to robustly quantify RNA levels in pancreas tissue 
sections, marked heterogeneity in Ins2 and Nkx2-2 was observed between β-cells. This 
included observing more immature (low Ins2, Nkx2-2) signatures at the islet periphery (55).  
 
CROP- and Peturb-seq: Differential gene expression can be obtained in single genome-
edited cells residing within a pooled population by directly linking guide RNA expression with 
individual cell transcriptome responses. For example via incorporation of polyadenylated 
sequences recognized by RNASeq, or combining gRNA with expression of a bar code (56). 
Both techniques allow high-throughput CRISPR screening of signaling/regulatory pathways in 
heterogeneous populations, and could potentially be used to understand the interactions 
underlying heterogeneity at different developmental stages.  
 
Computer modeling: To move beyond a qualitative overview (Fig.1), computer models show 
promise in reconciling divergent data sets generated from the range of available technologies 
(‘omics, imaging) and sample preparations (mouse, human, intact, dissociated). Computer 
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models accurately described how a defined β-cell population impacts islet stimulus-secretion, 
e.g. KATP mutant (30). Computer models also accurately described stimulus-secretion in sub-
populations uncovered through ChR2-stimulation (41). We envision islets could be modelled 
to incorporate sub-populations of β-cells with characteristics defined by single-cell 
approaches, and these models compared with functional studies. Rapid in-silico screening 
could then identify overlap between sub-populations identified using different experimental 
approaches and predict how they would influence islet function. A necessary step will be 
validating theoretical predictions with focused experiments.  
 
Summary:  
Spurred on by technological advances in single-cell genomics and imaging, the renewed 
interest in β-cell heterogeneity has changed our view of islet development and function. 
Pertinently, β-cell sub-populations have been identified that provide deeper mechanistic 
understanding of poorly-characterized processes such as proliferation, 
differentiation/maturation and stimulus-secretion. Thus, β-cell heterogeneity has highlighted 
new facets of islet plasticity, as well as how changes in this may affect islet function under 
conditions associated with diabetes. However, most studies to date have investigated 
dissociated cells, where many transcriptomic/protein features may be altered. Moreover, 
while the molecular signatures of sub-populations are well characterized, how these influence 
protein expression and functional state are poorly understood. Key to better understanding 
heterogeneity will be studies in the intact tissue and even in-vivo, the integration of multiple 
facets of a cell’s identity, and models with better fidelity for reading out gene and protein 
expression dynamics. Indeed, several gaps in our knowledge remain: how do we robustly 
define a β-cell sub-population? What is the molecular basis and functional role for 
heterogeneity among other endocrine cells (α-cells, δ-cells)? Are sub-populations of β-cells 
(or other cells) fixed into a specific functional state, or are they transitional? Recent and future 
technological developments should allow these questions to be addressed, and in doing so 
may reveal new genes and pathways that can be harnessed to improve therapy, coax β-cell 
regeneration, and inform de novo engineering of islets and islet transplantation.  
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FIGURE LEGENDS 
Figure 1: Summary of previously identified β-cell sub-populations using biomarker or single-
cell analyses. A: Summary of functionally component (‘functional’) cell sub-populations 
including their functional and gene/protein expression profile, incidence and how they change 
in conditions associated with diabetes. B: Summary of less-functionally component (‘non-
functional’) cell sub-populations. For A and B, those shaded are functionally defined via 
optogenetics in-situ. C: Schematic suggesting qualitative overlap between several identified 
sub-populations. Dashed lines indicate those defined via optogenetics in-situ. Note strong 
overlap between most identified larger populations, but the low incidence functional hub cell 
sub-population and non-functional Ucn3- sub-population show relatively lower overlap. This 
may however reflect the number and nature of the markers measured, as well as the 
functional readout. Note: i) GFPhigh increases from 10-40% with age (from 5-9w to 16-40w), 
GFPlow decreases from 50% to 10% with age. ii) PSA-NCAM+ is defined as top 50% 
expression. iii) Incidence was 50% in T2D donors. iv) Incidence was <30% in T2D donors. (v) 
Ucn3-, insulin+ located at islet periphery.  
 
Figure 2: Example for how heterogeneous cells can interact. A: Introducing Kir6.2[ΔN30, K185Q] 
into β-cells renders them non-glucose responsive. With a small (~10%) population of these 
non-functional cells in the islet (dark green) glucose-responsiveness is unchanged. However, 
with ~20% of these cells glucose responsiveness is lost. Glucose responsiveness is 
recovered by electrically isolating (Cx36ko) these non-functional cells. B: Conversely if a 
large proportion (~70%) of hyper-excitable Kir6.2[AAA] cells are introduced into the islet (light 
green), glucose-responsiveness remains, although this is lost when electrical coupling is lost 
(Cx36ko). C: In the native islet the number of intrinsically activated (light grey) cells increases 
as glucose concentration rises. However, only when a certain threshold of cells are activated, 
does Ca2+ elevate as a result of insufficient numbers of non-activated cells (dark grey), 
analogous to A and B. D: The presence of activated and non-activated cells can be further 
revealed by the KATP opener diazoxide, which renders only a small number of cells 
intrinsically inactive as observed in the absence of gap junction (GJ) coupling, but fully 
abolishes Ca2+ elevations in the presence of GJ coupling.   
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Figure 3: Heterogeneity in the intact islet. A: Different β-cell sub-populations co-exist within 
the islet, each characterized by different gene/protein expression patterns, morphological 
markers, glucose-responsiveness, insulin secretion, proliferative capacity and function, as 
also indicated in the table in Fig.1. Fltp- proliferative (blue) and Ucn3- transdifferentiating 
(purple) ‘immature’ non-functional populations are likely non-electrically coupled and thus do 
not significantly affect islet-wide responses to glucose. B: Optogenetic mapping reveals 
highly functional β-cell sub-populations with varying identity markers, metabolic properties 
and Ca2+ responses, but all with the ability to exert disproportionate control over coordination 
and intra-islet Ca2+ responses. This includes eNpHR3.0-silenced β-cells (hub cells, green) in 
which halorhodopsin activation and membrane hyperpolarization disproportionally silences 
the islet, and ChR2-activated cells (red), in which ChR2 activation and membrane 
depolarization disproportionally activates the islet. A population of cells in which ChR2 
activation has little effect also shows pacemaker-like characteristics owing to their higher 
intrinsic oscillation frequency.  
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Figure 2: Example for how heterogeneous cells can interact. A: Introducing Kir6.2[∆N30, K185Q] into β-cells 
renders them non-glucose responsive. With a small (~10%) population of these non-functional cells in the 
islet (dark green) glucose-responsiveness is unchanged. However, with ~20% of these cells glucose 
responsiveness is lost. Glucose responsiveness is recovered by electrically isolating (Cx36ko) these non-
functional cells. B: Conversely if a large proportion (~70%) of hyper-excitable Kir6.2[AAA] cells are 
introduced into the islet (light green), glucose-responsiveness remains, although this is lost when electrical 
coupling is lost (Cx36ko). C: In the native islet the number of intrinsically activated (light grey) cells 
increases as glucose concentration rises. However, only when a certain threshold of cells are activated, does 
Ca2+ elevate as a result of insufficient numbers of non-activated cells (dark grey), analogous to A and B. D: 
The presence of activated and non-activated cells can be further revealed by the KATP opener diazoxide, 
which renders only a small number of cells intrinsically inactive as observed in the absence of gap junction 
(GJ) coupling, but fully abolishes Ca2+ elevations in the presence of GJ coupling.    
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Figure 3: Heterogeneity in the intact islet. A: Different β-cell sub-populations co-exist within the islet, each 
characterized by different gene/protein expression patterns, morphological markers, glucose-
responsiveness, insulin secretion, proliferative capacity and function, as also indicated in the table in Fig.1. 
Fltp- proliferative (blue) and Ucn3- transdifferentiating (purple) ‘immature’ non-functional populations are 
likely non-electrically coupled and thus do not significantly affect islet-wide responses to glucose. B: 
Optogenetic mapping reveals highly functional β-cell sub-populations with varying identity markers, 
metabolic properties and Ca2+ responses, but all with the ability to exert disproportionate control over 
coordination and intra-islet Ca2+ responses. This includes eNpHr3.0-silenced β-cells (hub cells, green) in 
which halorhodopsin activation and membrane hyperpolarization disproportionally silences the islet, and 
ChR2-activated cells (red), in which ChR2 activation and membrane depolarization disproportionally 
activates the islet. A population of cells in which ChR2 activation has little effect also shows pacemaker-like 
characteristics owing to their higher intrinsic oscillation frequency.  
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